23. Jun 2025
Die Versorgung medizinisch kompromittierter Patienten stellt besondere Anforderungen an die Implantatchirurgie. In diesem Bego Webinar beleuchten PD. Dr. Dr. Matthias Tröltzsch und Prof. Dr. Dr. Bilal Al-Nawas evidenzbasiert und fallorientiert die besonderen Herausforderungen bei der Behandlung von Patienten unter Antikoagulation, mit Immunstörungen sowie Stoffwechselerkrankungen wie Diabetes mellitus und Osteoporose.
Ein besonderer Fokus liegt auf pharmakologischen Problemstellungen – etwa der Umgang mit Antiresorptiva, neuen Antikoagulanzien, Kortikosteroiden und immunsuppressiven Therapien.
Das Webinar vermittelt Wissen für implantologisch tätige Kolleginnen und Kollegen, die auch in komplexeren Fällen sicher agieren möchten.
Professor Dr. med. Dr. med. dent. Bilal Al-Nawas is Chairman of the Department of Oral, Maxillofacial and Plastic Surgery at the J. Gutenberg University of Mainz, Germany. He has been Adjunctive Associate Professor at Kyung Hee University School of Dentistry, Seoul, Korea since 2009. Professor Al-Nawas’ major clinical and scientific focus in dental implantology is on clinical studies and basic research. His clinical field of work is compromised patients with risk factors or local bone deficiency, as well as tumor and cleft reconstructions. He has published over 200 publications in peer-reviewed journals. He sits on the ITI Board of Directors and the ITI Research Committee, is an ITI Fellow and ITI Education Delegate of the ITI Section Germany. He was twice awarded “Best Teacher at the Medical Faculty”. He is Past President of the International Federation of Dental Anesthesiology Societies (IFDAS) and Secretary General of the German Society of Implantology (DGI).
Markus Tröltzsch is a specialist in oral and maxillofacial surgery. He worked as a senior physician at the Clinic and Polyclinic for Oral and Maxillofacial Surgery at the University Medical Center in Göttingen, Germany, and now runs the Center for Oral and Maxillofacial Surgery in Ansbach together with his brother. He is active in various specialist societies, is chairman of the Academy of Practice and Science (APW) of the DGZMK, and lectures and publishes frequently, particularly in the field of augmentation surgery and at the interface between medicine and dentistry.
Matthias Tröltzsch is a specialist in oral and maxillofacial surgery and a Fellow of the European Board of Oral and Maxillofacial Surgery, Head and Neck Surgery (FEBOMFS). He also holds the additional qualification “Plastic Surgery.” Together with his brother, he runs the Center for Oral and Maxillofacial Surgery in Ansbach, Germany. He habilitated at the Clinic and Polyclinic for Oral and Maxillofacial Surgery at Ludwig Maximilian University in Munich, where he holds a lectureship. He lectures and publishes widely, particularly in the fields of antiresorptives and oncology as well as at the interface between medicine and dentistry.